Breast Screening Atypia and Subsequent Development of Cancer in England

CompletedOBSERVATIONAL
Enrollment

3,238

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2023

Conditions
Breast Cancer
Interventions
OTHER

A diagnosis of atypia as part of the English screening programme

An atypia diagnosis of either ADH (including AIDEP), LISN (both ALH and LCIS) or FEA

Trial Locations (1)

CV47AL

Univesity of Warwick, Coventry

All Listed Sponsors
collaborator

University Hospitals Coventry and Warwickshire NHS Trust

OTHER

collaborator

King's College London

OTHER

collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

lead

University of Warwick

OTHER

NCT05402436 - Breast Screening Atypia and Subsequent Development of Cancer in England | Biotech Hunter | Biotech Hunter